Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

TG 100801

TG 100801 is a proagent that generates TG 100572 by de-esterification in development to treat age-related macular degeneration. TG 100572 is a multi-targeted kinase inhibitor which inhibits receptor tyrosine kinases and Src kinases; has IC50s of 2, 7, 2, 16, 13, 5, 0.5, 6, 0.1, 0.4, 1, 0.2 nM for VEGFR1, VEGFR2, FGFR1, FGFR2, PDGFRβ, Fgr, Fyn, Hck, Lck, Lyn, Src, Yes, respectively.

Product Specifications

CAS Number

867331-82-6

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

FGFR; PDGFR; Src; VEGFR

Type

Reference compound

Related Pathways

Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/TG-100801.html

Purity

98.61

Solubility

DMSO : 5.56 mg/mL (ultrasonic)

Smiles

O=C(C1=CC=CC=C1)OC2=CC=C(Cl)C(C3=CC(C)=C(N=C(NC(C=C4)=CC=C4OCCN5CCCC5)N=N6)C6=C3)=C2

Molecular Formula

C33H30ClN5O3

Molecular Weight

580.08

Precautions

H302, H315, H319, H335

References & Citations

[1]Palanki MS, et al. Development of prodrug 4-chloro-3- (5-methyl-3-{[4- (2-pyrrolidin-1-ylethoxy) phenyl]amino}-1,2,4-benzotriazin-7-yl) phenyl benzoate (TG100801) : a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration. J Med Chem. 2008 Mar 27;51 (6) :1546-59.|[2]Doukas, John, et al. Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema. Journal of Cellular Physiology (2008), 216 (1), 29-37.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 2

Isoform

PDGFRβ; VEGFR1/Flt-1; VEGFR2/KDR/Flk-1

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

NPL2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
K1446606 1.0 µg DNA

NPL2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

Sign In for Pricing
View Details
FKHR, phosphorylated (Ser319) (Forkhead Box Protein O1, Forkhead Box Protein O1A, Forkhead In Rhabdomyosarcoma, FOXO1A, FOXO1)
MBS626697-01 0.05 mg

FKHR, phosphorylated (Ser319) (Forkhead Box Protein O1, Forkhead Box Protein O1A, Forkhead In Rhabdomyosarcoma, FOXO1A, FOXO1)

Sign In for Pricing
View Details
FKHR, phosphorylated (Ser319) (Forkhead Box Protein O1, Forkhead Box Protein O1A, Forkhead In Rhabdomyosarcoma, FOXO1A, FOXO1)
MBS626697-02 5x 0.05 mg

FKHR, phosphorylated (Ser319) (Forkhead Box Protein O1, Forkhead Box Protein O1A, Forkhead In Rhabdomyosarcoma, FOXO1A, FOXO1)

Sign In for Pricing
View Details
ZCCHC18 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
50762061 1.0 µg DNA

ZCCHC18 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

Sign In for Pricing
View Details
MSX1 Human shRNA Lentiviral Particle (Locus ID 4487)
TL315500V 500 µL Each

MSX1 Human shRNA Lentiviral Particle (Locus ID 4487)

Sign In for Pricing
View Details
ZC3H8, NT (ZC3H8, ZC3HDC8, Zinc finger CCCH domain-containing protein 8) (AP) discontinued
044023-AP 200 µL

ZC3H8, NT (ZC3H8, ZC3HDC8, Zinc finger CCCH domain-containing protein 8) (AP) discontinued

Sign In for Pricing
View Details